申请人:AbbVie Inc.
公开号:US20140213610A1
公开(公告)日:2014-07-31
Compounds of Formula (I)
inhibit the PARP enzyme and are useful for treating a disease or a disorder associated with PARP. Also disclosed are pharmaceutical compositions comprising compounds of Formula (I), methods of treatment comprising compounds of Formula (I), and methods of inhibiting the PARP enzyme comprising compounds of Formula (I).
式(I)的化合物能够抑制PARP酶,可用于治疗与PARP相关的疾病或疾病。此外,还披露了包含式(I)化合物的制药组合物,包括使用式(I)化合物的治疗方法,以及使用式(I)化合物抑制PARP酶的方法。